$CINGW
Cingulate Inc.
Nasdaq · Pharmaceutical Preparations · Kansas City, KS
CINGW chart
What traders are saying about $CINGW
Latest postsCingulate Inc. news
- Form 8K Cingulate Inc For: 10 November By Investing.com
Investing.com Canada ·
- Cingulate CEO Discusses CTx-1301 FDA Regulatory Progress
TipRanks ·
- CING: Cingulate Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Quantisnow ·
- Cingulate Targets December 2026–January 2027 CTx-1301 NDA Resubmission
TradingView ·
- Cingulate CEO updates on ADHD drug NDA resubmission progress
StreetInsider ·
- Shane Schaffer, Cingulate Chairman and CEO, Provides Update on CTx-1301 in Interview with Innovators with Jane King
Yahoo Finance ·
- FDA requested Cingulate complete work before it plans to resubmit its ADHD drug
Stock Titan ·
- Cingulate Earnings Date and Estimates
MarketBeat ·
- Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma
Yahoo Finance ·
- CING: Second Quarter Results
Yahoo Finance ·
- Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness
Yahoo Finance ·
- Cingulate Publishes Peer-Reviewed Data Demonstrating CTx-1301’s Differentiated Pharmacokinetic Profile
Yahoo Finance ·
Cingulate Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$22.4M | -$16.6M | -$23.5M | -$17.7M |
| Diluted EPS | $-4.44 | $-10.86 | $-311.99 | $-29.35 |
| Total assets (year end) | $15.1M | $14.9M | $3.5M | $11.4M |
| Cash and equivalents (year end) | $11.0M | $12.2M | $52,416 | $5.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Cingulate Inc.
- Ticker
- CINGW (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Kansas City, KS
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1862150
- Former names
- Cingulate Inc.
Frequently asked questions
What exchange is Cingulate Inc. listed on?
Cingulate Inc. trades on the Nasdaq under the ticker symbol CINGW.
What industry is Cingulate Inc. in?
Cingulate Inc. is classified by the SEC under "Pharmaceutical Preparations".
Where is Cingulate Inc. headquartered?
Cingulate Inc.'s business address on file with the SEC is in Kansas City, KS.
When does Cingulate Inc.'s fiscal year end?
Cingulate Inc.'s fiscal year ends on December 31.